Mnemo Therapeutics announces €75 million Series A financing
Mnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, stronger T cells and best-in-class
Read moreMnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, stronger T cells and best-in-class
Read moreEthiopian Airlines has joined hands with BGI Health Ethiopia, a subsidiary of China’s biotech giant, the BGI Genomics Co., Ltd,
Read moreBy Mekonnen Teshome Tollera – As a science journalist, I read the article recently published by Dr. Tewolde Berhan Gebre
Read moreDigital trade within the context of the African Continental Free Trade Area (AfCFTA) will be at the center of discussions
Read moreEthiopia needs a national biotechnology policy in order to develop its capacity and apply the technology in agriculture, environment, health
Read more